These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
636 related articles for article (PubMed ID: 16394286)
41. FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours. van Oers JM; Wild PJ; Burger M; Denzinger S; Stoehr R; Rosskopf E; Hofstaedter F; Steyerberg EW; Klinkhammer-Schalke M; Zwarthoff EC; van der Kwast TH; Hartmann A Eur Urol; 2007 Sep; 52(3):760-8. PubMed ID: 17240035 [TBL] [Abstract][Full Text] [Related]
42. Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression. Mhawech P; Greloz V; Oppikofer C; Szalay-Quinodoz I; Herrmann F Cancer; 2004 Jun; 100(11):2367-75. PubMed ID: 15160340 [TBL] [Abstract][Full Text] [Related]
43. Her2 amplification distinguishes a subset of non-muscle-invasive bladder cancers with a high risk of progression. Chen PC; Yu HJ; Chang YH; Pan CC J Clin Pathol; 2013 Feb; 66(2):113-9. PubMed ID: 23087329 [TBL] [Abstract][Full Text] [Related]
44. Frequent FGFR3 mutations in urothelial papilloma. van Rhijn BW; Montironi R; Zwarthoff EC; Jöbsis AC; van der Kwast TH J Pathol; 2002 Oct; 198(2):245-51. PubMed ID: 12237885 [TBL] [Abstract][Full Text] [Related]
45. p53 expression compared with other prognostic factors in OMS grade-I stage-Ta transitional cell carcinoma of the bladder. Casetta G; Gontero P; Russo R; Pacchioni D; Tizzani A Eur Urol; 1997; 32(2):229-36. PubMed ID: 9286659 [TBL] [Abstract][Full Text] [Related]
46. Association of cyclin D1 and E1 expression with disease progression and biomarkers in patients with nonmuscle-invasive urothelial cell carcinoma of the bladder. Shariat SF; Ashfaq R; Sagalowsky AI; Lotan Y Urol Oncol; 2007; 25(6):468-75. PubMed ID: 18047954 [TBL] [Abstract][Full Text] [Related]
47. P16 immunoreactivity is an independent predictor of tumor progression in minimally invasive urothelial bladder carcinoma. Krüger S; Mahnken A; Kausch I; Feller AC Eur Urol; 2005 Apr; 47(4):463-7. PubMed ID: 15774242 [TBL] [Abstract][Full Text] [Related]
48. Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma. Krabbe LM; Bagrodia A; Lotan Y; Gayed BA; Darwish OM; Youssef RF; John G; Harrow B; Jacobs C; Gaitonde M; Sagalowsky AI; Shariat SF; Kapur P; Margulis V J Urol; 2014 Jan; 191(1):28-34. PubMed ID: 23871758 [TBL] [Abstract][Full Text] [Related]
49. The prognostic value of p53 nuclear overexpression and MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder. Popov Z; Hoznek A; Colombel M; Bastuji-Garin S; Lefrere-Belda MA; Bellot J; Abboh CC; Mazerolles C; Chopin DK Cancer; 1997 Oct; 80(8):1472-81. PubMed ID: 9338472 [TBL] [Abstract][Full Text] [Related]
50. Protein expression and gene copy number analysis of topoisomerase 2alpha, HER2 and P53 in minimally invasive urothelial carcinoma of the urinary bladder--a multitissue array study with prognostic implications. Krüger S; Lange I; Kausch I; Feller AC Anticancer Res; 2005; 25(1A):263-71. PubMed ID: 15816547 [TBL] [Abstract][Full Text] [Related]
51. Papillary urothelial neoplasm of low malignant potential: reliability of diagnosis and outcome. Campbell PA; Conrad RJ; Campbell CM; Nicol DL; MacTaggart P BJU Int; 2004 Jun; 93(9):1228-31. PubMed ID: 15180612 [TBL] [Abstract][Full Text] [Related]
52. Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases. Pan CC; Chang YH; Chen KK; Yu HJ; Sun CH; Ho DM Am J Clin Pathol; 2010 May; 133(5):788-95. PubMed ID: 20395527 [TBL] [Abstract][Full Text] [Related]
53. Strong immunohistochemical expression of fibroblast growth factor receptor 3, superficial staining pattern of cytokeratin 20, and low proliferative activity define those papillary urothelial neoplasms of low malignant potential that do not recur. Barbisan F; Santinelli A; Mazzucchelli R; Lopez-Beltran A; Cheng L; Scarpelli M; van der Kwast T; Montironi R Cancer; 2008 Feb; 112(3):636-44. PubMed ID: 18072261 [TBL] [Abstract][Full Text] [Related]
54. Expression of CD44 standard and variant-v6 proteins in transitional cell bladder tumours and their relation to prognosis during a long-term follow-up. Lipponen P; Aaltoma S; Kosma VM; Ala-Opas M; Eskelinen M J Pathol; 1998 Oct; 186(2):157-64. PubMed ID: 9924431 [TBL] [Abstract][Full Text] [Related]
55. The prognostic value of P-cadherin in non-muscle-invasive bladder cancer. Wang P; Lin SL; Zhang LH; Li Z; Liu Q; Gao JX; Liu DM; Bo JJ; Huang YR Eur J Surg Oncol; 2014 Mar; 40(3):255-9. PubMed ID: 24429027 [TBL] [Abstract][Full Text] [Related]
56. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer. Korkolopoulou P; Christodoulou P; Kapralos P; Exarchakos M; Bisbiroula A; Hadjiyannakis M; Georgountzos C; Thomas-Tsagli E Pathol Res Pract; 1997; 193(11-12):767-75. PubMed ID: 9521509 [TBL] [Abstract][Full Text] [Related]
57. p16(INK4a) /Ki-67 dual labelling as a marker for the presence of high-grade cancer cells or disease progression in urinary cytopathology. Piaton E; Advenier AS; Carré C; Decaussin-Petrucci M; Mege-Lechevallier F; Ruffion A Cytopathology; 2013 Oct; 24(5):327-34. PubMed ID: 23003335 [TBL] [Abstract][Full Text] [Related]
58. Loss of heterozygosity at 9q32-33 (DBC1 locus) in primary non-invasive papillary urothelial neoplasm of low malignant potential and low-grade urothelial carcinoma of the bladder and their associated normal urothelium. Lopez-Beltran A; Alvarez-Kindelan J; Luque RJ; Blanca A; Quintero A; Montironi R; Cheng L; Gonzalez-Campora R; Requena MJ J Pathol; 2008 Jul; 215(3):263-72. PubMed ID: 18452128 [TBL] [Abstract][Full Text] [Related]
59. P27(Kip1) and Ki-67 expression analysis in transitional cell carcinoma of the bladder. Dybowski B; Kupryjańczyk J; Rembiszewska A; Pykało R; Borkowski A Urol Res; 2003 Dec; 31(6):397-401. PubMed ID: 14517702 [TBL] [Abstract][Full Text] [Related]
60. Correlation of Ki-67 and p53 with the new World Health Organization/International Society of Urological Pathology Classification System for Urothelial Neoplasia. Cina SJ; Lancaster-Weiss KJ; Lecksell K; Epstein JI Arch Pathol Lab Med; 2001 May; 125(5):646-51. PubMed ID: 11300936 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]